학술논문

Mutations in SLC25A46, encoding a UGO1-like protein, cause an optic atrophy spectrum disorder.
Document Type
article
Source
Nature genetics. 47(8)
Subject
COS Cells
Embryo
Nonmammalian
Animals
Animals
Genetically Modified
Zebrafish
Humans
Optic Atrophy
Autosomal Dominant
Charcot-Marie-Tooth Disease
Genetic Predisposition to Disease
Phosphate Transport Proteins
Muscle Proteins
Saccharomyces cerevisiae Proteins
Membrane Proteins
Mitochondrial Proteins
Microscopy
Confocal
Microscopy
Electron
Transmission
Pedigree
Sequence Analysis
DNA
RNA Interference
Protein Binding
Mutation
Female
Male
Mitochondrial Membranes
HEK293 Cells
Exome
Chlorocebus aethiops
Brain Disorders
Genetics
Neurosciences
Rare Diseases
Eye Disease and Disorders of Vision
Neurological
Biological Sciences
Medical and Health Sciences
Developmental Biology
Language
Abstract
Dominant optic atrophy (DOA) and axonal peripheral neuropathy (Charcot-Marie-Tooth type 2, or CMT2) are hereditary neurodegenerative disorders most commonly caused by mutations in the canonical mitochondrial fusion genes OPA1 and MFN2, respectively. In yeast, homologs of OPA1 (Mgm1) and MFN2 (Fzo1) work in concert with Ugo1, for which no human equivalent has been identified thus far. By whole-exome sequencing of patients with optic atrophy and CMT2, we identified four families with recessive mutations in SLC25A46. We demonstrate that SLC25A46, like Ugo1, is a modified carrier protein that has been recruited to the outer mitochondrial membrane and interacts with the inner membrane remodeling protein mitofilin (Fcj1). Loss of function in cultured cells and in zebrafish unexpectedly leads to increased mitochondrial connectivity, while severely affecting the development and maintenance of neurons in the fish. The discovery of SLC25A46 strengthens the genetic overlap between optic atrophy and CMT2 while exemplifying a new class of modified solute transporters linked to mitochondrial dynamics.